Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

BRD3308

🥰Excellent
Catalog No. T8233Cas No. 1550053-02-5

BRD3308 is a highly selective inhibitor of HDAC3(IC50 of 54 nM), attenuating PE-mediated phosphorylation of ERK but not JNK.

BRD3308

BRD3308

🥰Excellent
Purity: 97%
Catalog No. T8233Cas No. 1550053-02-5
BRD3308 is a highly selective inhibitor of HDAC3(IC50 of 54 nM), attenuating PE-mediated phosphorylation of ERK but not JNK.
Pack SizePriceAvailabilityQuantity
1 mg$38In Stock
2 mg$54In Stock
5 mg$87In Stock
10 mg$128In Stock
25 mg$233In Stock
50 mg$352In Stock
100 mg$528In Stock
1 mL x 10 mM (in DMSO)$97In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "BRD3308"

Select Batch
Purity:97%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
BRD3308 is a highly selective inhibitor of HDAC3(IC50 of 54 nM), attenuating PE-mediated phosphorylation of ERK but not JNK.
Targets&IC50
HDAC1:1260 nM , HDAC1:5100 nM (Ki) , HDAC3:29 nM (Ki) , HDAC3:54 nM , HDAC2:1340 nM , HDAC2:6300 nM (Ki)
In vivo
BRD3308 is a selective HDAC3 inhibitor,to reduce hyperglycaemia and increase insulin secretion in a rat model of type 2 diabetes.?At diabetes onset, an ambulatory hyperglycaemic clamp was performed.?HDAC3 inhibition improved hyperglycaemia over the study period without affecting weight gain.?At the end of the hyperglycaemic clamp, circulating insulin levels were significantly higher in BRD3308-treated rats.?Pancreatic insulin staining and contents were also significantly higher.?These findings highlight HDAC3 as a key therapeutic target for β-cell protection in type 2 diabetes[1].
Animal Research
Male Zucker Diabetic Fatty (Obese) rats (6-week-old); 5 mg/kg; Intraperitoneal injection; every second day
Chemical Properties
Molecular Weight287.29
FormulaC15H14FN3O2
Cas No.1550053-02-5
SmilesCC(=O)Nc1ccc(cc1)C(=O)Nc1ccc(F)cc1N
Relative Density.1.382 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 52 mg/mL (181 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4808 mL17.4040 mL34.8080 mL174.0402 mL
5 mM0.6962 mL3.4808 mL6.9616 mL34.8080 mL
10 mM0.3481 mL1.7404 mL3.4808 mL17.4040 mL
20 mM0.1740 mL0.8702 mL1.7404 mL8.7020 mL
50 mM0.0696 mL0.3481 mL0.6962 mL3.4808 mL
100 mM0.0348 mL0.1740 mL0.3481 mL1.7404 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BRD3308 | purchase BRD3308 | BRD3308 cost | order BRD3308 | BRD3308 chemical structure | BRD3308 in vivo | BRD3308 formula | BRD3308 molecular weight